C.A. Medbery

Papers

Total Citations

H-Index

About

C.A. Medbery is a radiation oncologist whose research focuses on optimizing stereotactic body radiotherapy (SBRT) for prostate cancer, with a particular emphasis on patient-reported outcomes and dosimetric predictors of treatment-related toxicity. In their most-cited work, a secondary analysis of a multi-institutional trial, Medbery identified key patient and dosimetric factors that predict genitourinary and bowel quality of life following prostate SBRT. This contribution is vital for personalizing treatment planning, helping clinicians minimize side effects while maintaining tumor control. Although early in their citation trajectory, this study provides foundational insights for prospective trials and clinical practice guidelines. Medbery’s work bridges the gap between technical dosimetry and real-world patient experience, underscoring a commitment to evidence-based, patient-centered care. Their research is particularly relevant for trainees and practitioners seeking to refine SBRT delivery and improve long-term quality of life for prostate cancer survivors.